AbbVie's office in Russia: BC White Gardens, building A
Business Address: 125196, Moscow, st. Lesnaya, 7, BC "White Gardens", building "A"
Phone: +74952584277
Fax: 7 495 258 42 87
E-mail: russia.info@abbvie.com
| Type | Public company |
|---|---|
| Traded as |
|
| Industry | Biopharmaceutical |
| Founded | 2013 (2013) |
| Headquarters | North Chicago, Illinois, U.S. |
| Area served | Worldwide (170+ countries) |
| Key people | Richard A. Gonzalez (Chairman and CEO) Michael Severino (Vice Chairman and President) |
| Products | Pharmaceutical drugs
|
| Revenue |  US$56.20 billion (2021) |
| Operating income |  US$17.92 billion (2021) |
| Net income | US$11.54 billion (2021) |
| Total assets | US$146.53 billion (2021) |
| Total equity | US$15.44 billion (2021) |
| Number of employees | 50,000 (Jan 2022) |
| Website | abbvie.com |
We’re a company that takes on the toughest health challenges. But we do more than treat diseases—we aim to make a remarkable impact on people’s lives. We are AbbVie, a highly focused research-driven biopharmaceutical company. Our ~47,000 employees are scientists, researchers, communicators, manufacturing specialists and regulatory experts located around the globe. We come up with new approaches to addressing today’s health issues—from life-threatening illness to chronic conditions. We target specific difficult-to-cure diseases where we can leverage our core R&D expertise to advance science. We’re constantly working to create solutions that go beyond treating the illness to have a positive impact on patients’ lives, on societies—and on science itself. At AbbVie, we see a future full of possibility, where health is in reach and patient lives are improved. See our employees, our science and our hope for tomorrow